Nobel Biocare could pay $1.3 million to settle a class-action lawsuit over allegedly defective dental implants.
Nobel Biocare Holding may be able to settle a class action lawsuit involving 1,000s of dentists for $1.3 million after a federal judge tentatively OK'd the deal.
The class action, headed by Dr. Jason Yamada, includes any U.S. dentists who bought Nobel implant products (except the company's NobelDirect Groovy device) – more than 2,900 dentists.
The FDA's Dental Products Panel is scheduled to deliberate on whether the agency should lower blade-form dental implants to a lower risk class.
An FDA advisory panel will consider in July whether to down-classify blade-form endosseous dental implants from the highest risk category to a less stringent class.
The FDA is now proposing to reclassify this pre-amendments class III device into class II because the federal watchdog believes that special controls, together with general controls, can effectively mitigate risks to health posed by these devices, according to the agency's federal register notice.
Colgate-Palmolive files for U.S. patent protection for a toothbrush with a caffeine patch.
Here's a good way to eliminate coffee breath and still get your morning off on the right foot.
An International Trade Commission judge finds that Pakistani dental device maker ClearCorrect infringes 7 Align Technology patents.
Align Technology (NSDQ:ALGN) said a judge with the International Trade Commission found that Pakistani dental device maker ClearCorrect and a U.S. affiliate infringe 7 of Align's patents.
Dental devices maker Align Technologies gains almost 5% on Wall Street after reporting adjusted per-share earnings about 30% higher than analysts' expectations.
Align Technology (NSDQ:ALGN) got a big Wall Street boost today after reporting a big increase in sales and strong growth in shipments of its flagship Invisalign product.
Dentsply details its plans to replace ex-CFO William Jellison, who jumped ship ater 15 years for medical device company Stryker.
Dentsply International (NSDQ:XRAY) detailed its plans to replace ex-CFO William Jellison, who jumped ship today for medical device company Stryker (NYSE:SYK).
Stryker Corp. names Dentsply CFO William Jellison to be its new CFO, replacing interim finance chief Dean Bergy.
Medical device company Stryker (NYSE:SYK) said it hired William Jellison, the finance chief for Dentsply International (NSDQ:XRAY), to be its new CFO.